Develops a PREssure-controlled intermittent coronary sinus occlusion technology for heart patients
Miracor Medical Systems has raised €15M across 3 funding rounds from 3 investors, most recently a Series B round in Jan 2015. Based in Vienna, Austria; founded 2008; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2015-01-01 | Series B | €4.5M | BioMed Partners,Earlybird Venture Capital | View deal → |
| 2012-02-01 | Grant | €2.7M | — | View deal → |
| 2011-10-01 | Series B | €7.4M | Austria Wirtschaftsservice,Earlybird Venture Capital | View deal → |
